Capstone Asset Management’s ResMed RMD Stock Holding History

Capstone Asset Management’s Portfolio RMD Stock Details RMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q2	$7.98M	Buy	102,457 +1,485	+1%	+$106K	0.22%	119
2017 Q1	$7.27M	Buy	100,972 +8,909	+10%	+$616K	0.2%	124
2016 Q4	$5.71M	Buy	92,063 +4,375	+5%	+$268K	0.16%	143
2016 Q3	$5.68M	Buy	87,688 +1,715	+2%	+$114K	0.16%	142
2016 Q2	$5.44M	Buy	85,973 +2,540	+3%	+$150K	0.16%	140
2016 Q1	$4.82M	Buy	83,433 +70,582	+549%	+$4M	0.14%	179
2015 Q4	$690K	Buy	12,851 +10	+0.1%	+$564	0.02%	727
2015 Q3	$654K	Buy	12,841 +1,530	+14%	+$82.4K	0.02%	747
2015 Q2	$638K	Sell	11,311 -100	-0.9%	-$6.31K	0.02%	792
2015 Q1	$819K	Buy	11,411 +1,010	+10%	+$65.6K	0.02%	767
2014 Q4	$583K	Sell	10,401 -190	-2%	-$9.92K	0.02%	943
2014 Q3	$522K	Buy	10,591 +170	+2%	+$8.66K	0.02%	989
2014 Q2	$528K	Sell	10,421 -2,250	-18%	-$112K	0.02%	1028
2014 Q1	$566K	Sell	12,671 -1,330	-9%	-$59.7K	0.02%	970
2013 Q4	$659K	Sell	14,001 -11,759	-46%	-$595K	0.02%	901
2013 Q3	$1.36M	Buy	25,760 +650	+3%	+$31.5K	0.03%	611
2013 Q2	$1.13M	Buy	+25,110	New	+$1.19M	0.03%	641

Other funds holding RMD

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

CBOA

Commonwealth Bank of Australia Sydney, NSW, Australia $231M AUM

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Capstone Asset Management's RMD Position: Q2 2017 in Review

Capstone Asset Management increased its ResMed (RMD) stake by 1.5% in Q2 2017, buying an estimated $106K and bringing the position to 102,457 shares worth $7.98M. The position accounts for 0.22% of the portfolio, ranked #119.

Capstone Asset Management first reported a position in RMD in Q2 2013 and has held it in 17 quarters since. 339 funds tracked by Wall St. Rank hold RMD as of Q2 2017.

Capstone Asset Management held 102,457 shares of ResMed worth $7.98M as of Q2 2017.
Capstone Asset Management bought 1,485 ResMed shares in Q2 2017, an estimated $106K.
ResMed made up 0.22% of Capstone Asset Management's portfolio in Q2 2017, its #119 holding.
Capstone Asset Management first reported a position in ResMed in Q2 2013 and has held it in 17 quarters since.
339 funds tracked by Wall St. Rank held ResMed as of Q2 2017.

Based on Capstone Asset Management's 13F filing for Q2 2017, filed 10 Jul 2017.